BALYASNY ASSET MANAGEMENT L.P. - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q3 2023$30,521,546
+1179.7%
1,102,657
+1367.5%
0.06%
+463.6%
Q2 2021$2,385,000
-56.7%
75,137
-37.4%
0.01%
-59.3%
Q1 2021$5,508,000120,0520.03%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 5,524,031$151,966,00028.85%
Ponoi II Management, LLC 685,011$18,845,00027.92%
Ponoi Management, LLC 685,011$18,845,00016.73%
Column Group LLC 3,347,245$92,083,00010.48%
TRV GP IV, LLC 1,419,900$39,061,0008.86%
Cormorant Asset Management, LP 3,144,700$86,511,0003.52%
Boxer Capital, LLC 3,484,264$95,852,0003.35%
BVF INC/IL 2,485,049$68,364,0002.67%
Casdin Capital, LLC 2,800,000$77,028,0001.92%
COMMODORE CAPITAL LP 226,228$6,224,0001.64%
View complete list of REVOLUTION MEDICINES INC shareholders